{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:05:24Z","timestamp":1789635924149,"version":"4.0.0"},"reference-count":41,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008836","name":"Gaziantep University Scientific Research Projects Coordination Unit","doi-asserted-by":"publisher","award":["TF.UT.19.45"],"award-info":[{"award-number":["TF.UT.19.45"]}],"id":[{"id":"10.13039\/501100008836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: In Hodgkin lymphoma (HL), cytokine-related genetic variation may influence disease susceptibility and clinical outcomes. This study investigated polymorphisms in tumor necrosis factor-alpha (TNF-\u03b1), transforming growth factor-beta 1 (TGF-\u03b21), interferon-gamma (IFN-\u03b3), interleukin-6 (IL-6), and interleukin-10 (IL-10) in relation to HL susceptibility and progression-free survival (PFS). Methods: Seventy patients with HL and 70 healthy controls were included. Cytokine gene polymorphisms were analyzed from peripheral blood using sequence-specific primer polymerase chain reaction (PCR-SSP). Multiple comparisons were controlled using the Benjamini\u2013Hochberg false discovery rate (FDR), and prognostic associations were evaluated using Firth penalized Cox regression. Results: Several genotype-level associations were nominally significant before multiple-testing correction, including TNF-\u03b1 (\u2212308) GA, IFN-\u03b3 (+874) TT, IL-6 (\u2212174) GG, TGF-\u03b21 codon 10 TT, IL-10 (\u22121082) GG, IL-10 (\u2212819) CC, and IL-10 (\u2212592) CC genotypes. In addition, selected TGF-\u03b21 and IL-10 predefined multilocus genotype combinations showed nominal associations with HL susceptibility. However, none of these genotype-level or multilocus genotype-combination associations remained statistically significant after FDR correction. In contrast, significant allele-level associations persisted after FDR adjustment for the IL-6 (\u2212174) G allele, TGF-\u03b21 codon 10 T allele, and IL-10 (\u22121082) G, IL-10 (\u2212819) C, and IL-10 (\u2212592) C alleles. Bone marrow involvement remained associated with inferior PFS (HR = 11.62, 95% confidence interval (CI): 3.61\u201334.66; p &lt; 0.001), although the wide CI warrants cautious interpretation. The IL-6 (\u2212174) CC genotype also showed an association with inferior PFS (HR = 7.09, 95% CI: 1.34\u201325.29; p = 0.025); however, this estimate was based on only two carriers and should be considered exploratory. Conclusions: Selected cytokine gene variants, particularly at the allele level, may be associated with HL susceptibility. The prognostic association of IL-6 (\u2212174) CC requires confirmation in larger cohorts.<\/jats:p>","DOI":"10.3390\/jcm15187210","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:17Z","timestamp":1789632197000},"page":"7210","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of TNF-\u03b1, TGF-\u03b21, IFN-\u03b3, IL-6, and IL-10 Gene Polymorphisms with Hodgkin Lymphoma: Susceptibility and Clinical Outcomes"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-8819","authenticated-orcid":false,"given":"Handan","family":"Haydaroglu Sahin","sequence":"first","affiliation":[{"name":"Division of Hematology, Gaziantep University Hospital, Gaziantep 27310, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Duygu Deniz","family":"Ustul","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Kusadas\u0131 Government Hospital, Ayd\u0131n 09400, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Pelin","family":"Yorulmaz","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Gaziantep City Hospital, Gaziantep 27470, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/eurpub\/ckaf002","article-title":"Increasing incidence and prevalence of Hodgkin\u2019s lymphoma in Finland: A population-based registry study","volume":"35","author":"Antikainen","year":"2025","journal-title":"Eur. J. Public Health"},{"key":"ref_2","unstructured":"Pizzo, P.A., and Poplack, D.G. (2006). Hodgkin lymphoma. Principles and Practice of Pediatric Oncology, Lippincott Williams & Wilkins. [5th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2005.1.231","article-title":"Immunobiology and pathophysiology of Hodgkin lymphomas","volume":"2005","author":"Poppema","year":"2005","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/annonc\/13.S1.52","article-title":"Chemokines, cytokines and their receptors in Hodgkin\u2019s lymphoma cell lines and tissues","volume":"13","author":"Maggio","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/annonc\/mdm132","article-title":"Polymorphism in cytokine genes as prognostic markers in Hodgkin\u2019s lymphoma","volume":"18","author":"Hohaus","year":"2007","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cyto.2013.08.002","article-title":"Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts","volume":"64","author":"Maurer","year":"2013","journal-title":"Cytokine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2003-08-2860","article-title":"IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma","volume":"103","author":"Cozen","year":"2004","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/S1516-8913201500287","article-title":"Involvement of transforming growth factor beta-1 (TGF\u03b21) cytokine and FOXP3 transcription factor genetic polymorphisms in hematological malignancies","volume":"58","author":"Vitiello","year":"2015","journal-title":"Braz. Arch. Biol. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2005.12.010","article-title":"TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin\u2019s lymphoma patients","volume":"33","author":"Mazur","year":"2006","journal-title":"Cytokine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: Final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Girinsky","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43042-019-0043-0","article-title":"TNF-\u03b1 \u2212308 G>A and IL10 \u22121082A>G polymorphisms as potential risk factors for lymphoproliferative disorders in autoimmune rheumatic diseases","volume":"21","author":"Tayel","year":"2020","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1517\/14656566.2010.515979","article-title":"Hodgkin\u2019s lymphoma therapy: Past, present, and future","volume":"11","author":"Rathore","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: Diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1073\/pnas.95.16.9465","article-title":"Interleukin 10 secretion in relation to human IL-10 locus haplotypes","volume":"95","author":"Eskdale","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa022060","article-title":"Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation","volume":"349","author":"Lin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1182\/blood-2003-06-1850","article-title":"Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma","volume":"103","author":"Baseggio","year":"2004","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/1042819021000035590","article-title":"Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin\u2019s lymphoma","volume":"44","author":"Cunningham","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819031000119316","article-title":"Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma","volume":"44","author":"Munro","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1634\/theoncologist.2012-0291","article-title":"Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma","volume":"18","author":"Schoof","year":"2013","journal-title":"Oncologist"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/hmg\/ddh187","article-title":"Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level","volume":"13","author":"Kurreeman","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","first-page":"66","article-title":"The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals","volume":"13","author":"Kilpinen","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: From basic science to medicine\u201440 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.bjc.6603586","article-title":"Interleukin-6 gene amplification and shortened survival in glioblastoma patients","volume":"96","author":"Tchirkov","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12098-019-02902-x","article-title":"Prognostic significance of IL-6 in Hodgkin lymphoma","volume":"86","author":"Bhethanabhotla","year":"2019","journal-title":"Indian. J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.2004.05353.x","article-title":"Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin\u2019s lymphoma","volume":"128","author":"Cordano","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: A master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10428199609052433","article-title":"Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma","volume":"20","author":"Macia","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The \u2212308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwp383","article-title":"Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium","volume":"171","author":"Skibola","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Berm\u00fadez, M., L\u00f3pez-Mej\u00edas, R., Gonz\u00e1lez-Juanatey, C., Corrales, A., Robledo, G., Casta\u00f1eda, S., Miranda-Filloy, J.A., Blanco, R., Fern\u00e1ndez-Guti\u00e9rrez, B., and Balsa, A. (2012). Analysis of the interferon gamma (rs2430561, +874T\/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047166"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2009-10-250134","article-title":"Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma","volume":"115","author":"Stern","year":"2010","journal-title":"Blood"},{"key":"ref_36","first-page":"1615","article-title":"Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines","volume":"11","author":"Chaouchi","year":"1995","journal-title":"Oncogene"},{"key":"ref_37","first-page":"CR33","article-title":"Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin\u2019s lymphomas","volume":"10","author":"Woszczyk","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V89.3.941","article-title":"Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta","volume":"89","author":"Douglas","year":"1997","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood-2011-09-378414","article-title":"A retrospective multicenter analysis of elderly Hodgkin lymphoma: Outcomes and prognostic factors in the modern era","volume":"119","author":"Evens","year":"2012","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e2014053","DOI":"10.4084\/mjhid.2014.053","article-title":"Prognostic factors in Hodgkin lymphoma","volume":"6","author":"Cuccaro","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1200\/JCO.2005.205.60","article-title":"German Hodgkin Study Group. Role of hematotoxicity and sex in patients with Hodgkin\u2019s lymphoma: An analysis from the German Hodgkin Study Group","volume":"23","author":"Klimm","year":"2005","journal-title":"J. Clin. Oncol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7210\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:41:29Z","timestamp":1789634489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":41,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187210"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187210","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}